Select Medical Q3 2020 Earnings Report
Key Takeaways
Select Medical Holdings Corporation reported a 2.2% increase in net operating revenues to $1,423.9 million for the third quarter ended September 30, 2020. Net income increased by 137.2% to $104.5 million, and earnings per common share was $0.57 on a fully diluted basis.
Net operating revenues increased by 2.2% to $1,423.9 million compared to the same quarter last year.
Income from operations increased by 27.0% to $156.1 million compared to the same quarter last year.
Net income increased by 137.2% to $104.5 million compared to the same quarter last year.
Earnings per common share was $0.57 on a fully diluted basis, compared to $0.23 for the same quarter last year.
Select Medical
Select Medical
Select Medical Revenue by Segment
Forward Guidance
Select Medical expects for the full year of 2020 consolidated net operating revenues to be in the range of $5.44 billion to $5.50 billion and Adjusted EBITDA for the full year of 2020 to be in the range of $745.0 million to $765.0 million. Select Medical now expects fully diluted earnings per common share for the full year 2020 to be in the range of $1.65 to $1.75 and adjusted earnings per common share for the full year 2020 to be in the range of $1.61 to $1.71.
Revenue & Expenses
Visualization of income flow from segment revenue to net income